$ELDN
Eledon Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Irvine, CA
ELDN chart
What traders are saying about $ELDN
Latest postsEledon Pharmaceuticals, Inc. news
- Eledon Pharmaceuticals presents patient-reported outcomes data from BESTOW trial
TipRanks ·
- Eledon Pharmaceuticals Presents Phase 2 BESTOW Trial Data Showing Sustained Improvements in Quality of Life and Symptom Burden with Tegoprubart Compared to Tacrolimus at American Society of Nephrology Kidney Week 2026 Annual Meeting
GlobeNewswire ·
- One kidney transplant treatment lowered symptom scores over a year; tacrolimus scores ended above where they started.
Stock Titan ·
- Eledon Pharmaceuticals (ELDN) Institutional Ownership 2026
MarketBeat ·
Eledon Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$45.6M | -$36.2M | -$116.5M | -$88.0M |
| Diluted EPS | $-0.52 | $-0.66 | $-4.73 | $-6.16 |
| Total assets (year end) | $169.0M | $177.4M | $89.1M | $92.8M |
| Cash and equivalents (year end) | $22.8M | $20.5M | $4.6M | $56.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Eledon Pharmaceuticals, Inc.
- Ticker
- ELDN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Irvine, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1404281
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Frequently asked questions
What exchange is Eledon Pharmaceuticals, Inc. listed on?
Eledon Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ELDN.
What industry is Eledon Pharmaceuticals, Inc. in?
Eledon Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Eledon Pharmaceuticals, Inc. headquartered?
Eledon Pharmaceuticals, Inc.'s business address on file with the SEC is in Irvine, CA.
When does Eledon Pharmaceuticals, Inc.'s fiscal year end?
Eledon Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Eledon Pharmaceuticals, Inc. report?
Eledon Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2016, according to its SEC filings.